Home Newsfeeds Apple To Reduce iPhone14 Plus Production After Weak Demand

Apple To Reduce iPhone14 Plus Production After Weak Demand

– Fox Business Report

byBenzinga Newsdesk

October 27, 2022

1 minute read

– Fox Business Report

HC Wainwright & Co. Reiterates Buy on Tarsus Pharmaceuticals, Maintains $40 Price Target

By Benzinga Newsdesk

March 15, 6:11 AM

HC Wainwright & Co. analyst Oren Livnat reiterates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and maintains $40 price target.

TARS

Morgan Stanley Maintains Equal-Weight on Lions Gate Entertainment Corporation Class B Non-Voting Shares, Lowers Price Target to $8.5

By Benzinga Newsdesk

November 4, 9:06 AM

Morgan Stanley analyst Benjamin Swinburne maintains Lions Gate Entertainment Corporation Class B Non-Voting Shares (NYSE:LGF) with a Equal-Weight and lowers the price target from $9 to $8.5.

LGF

UBS Downgrades C.H. Robinson Worldwide to Sell, Lowers Price Target to $81

By Benzinga Newsdesk

January 4, 8:15 AM

UBS analyst Thomas Wadewitz downgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Neutral to Sell and lowers the price target from $90 to $81.

CHRW

Altamira Therapeutics Provides Update On Clinical Trials With Bentrio; Interim Analysis Shows Superior Efficacy Of Bentrio In Seasonal Allergic Rhinitis

By Benzinga Newsdesk

January 24, 9:18 AM

HAMILTON, BERMUDA , Jan. 24, 2023 (GLOBE NEWSWIRE) -- Interim analysis of Australian NASAR trial in seasonal allergic rhinitis shows statistically significant improvement with Bentrio® in nasal symptom primary

CYTO

Apple To Reduce iPhone14 Plus Production After Weak Demand

Related Posts

HC Wainwright & Co. Reiterates Buy on Tarsus Pharmaceuticals, Maintains $40 Price Target

Morgan Stanley Maintains Equal-Weight on Lions Gate Entertainment Corporation Class B Non-Voting Shares, Lowers Price Target to $8.5

UBS Downgrades C.H. Robinson Worldwide to Sell, Lowers Price Target to $81

Altamira Therapeutics Provides Update On Clinical Trials With Bentrio; Interim Analysis Shows Superior Efficacy Of Bentrio In Seasonal Allergic Rhinitis